Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants

Bibliographic Details
Main Authors:	Bin Tu, Huiyuan Wang, Xinran An, Jingkun Qu, Qianqian Li, Yanrong Gao, Mingjie Shi, Hong Qiu, Yongzhuo Huang
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	SARS-CoV-2 Delta variant Heparan sulfate Spike protein Heparin nanoparticle Pulmonary delivery
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383522000491

Similar Items

Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?
by: H.B. Nader, et al.
Published: (1999-05-01)

Using heparin molecules to manage COVID‐2019
by: Jian Liu, et al.
Published: (2020-05-01)

Recombinant Heparin—New Opportunities
by: Charles Alexander Glass
Published: (2018-12-01)

Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017-10-01)

Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
by: Adrianne L. Gelbach, et al.
Published: (2022-08-01)

Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?
by: Brooke L. Farrugia, et al.
Published: (2015-03-01)

Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars
by: Katarzyna A. Uniewicz, et al.
Published: (2014-06-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use
by: Paola Chiodelli, et al.
Published: (2015-04-01)

Elucidating the Binding Mode between Heparin and Inflammatory Cytokines by Molecular Modeling
by: Dr. Mingjia Yu, et al.
Published: (2021-10-01)

Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors
by: Ha Na Kim, et al.
Published: (2017-05-01)

The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives
by: Noemi Veraldi, et al.
Published: (2020-01-01)

Noncovalent hyaluronan crosslinking by TSG-6: Modulation by heparin, heparan sulfate, and PRG4
by: Yun Jin Ashley Sin, et al.
Published: (2022-10-01)

Assessing Genetic Algorithm-Based Docking Protocols for Prediction of Heparin Oligosaccharide Binding Geometries onto Proteins
by: Samuel G. Holmes, et al.
Published: (2023-11-01)

Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity
by: Cinzia Lanzi, et al.
Published: (2018-11-01)

1H and 15N NMR Analyses on Heparin, Heparan Sulfates and Related Monosaccharides Concerning the Chemical Exchange Regime of the N-Sulfo-Glucosamine Sulfamate Proton
by: Vitor H. Pomin
Published: (2016-09-01)

Heparin: Past, Present, and Future
by: Eziafa I. Oduah, et al.
Published: (2016-07-01)

Binding of the human antioxidation protein α1-microglobulin (A1M) to heparin and heparan sulfate. Mapping of binding site, molecular and functional characterization, and co-localization in vivo and in vitro
by: Jesper Bergwik, et al.
Published: (2021-05-01)

Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment
by: John Hogwood, et al.
Published: (2023-02-01)

Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical
by: Elisabeth Gludovacz, et al.
Published: (2021-09-01)

The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics
by: Ariana A. Vasconcelos, et al.
Published: (2017-08-01)

Enoxaparin and Pentosan Polysulfate Bind to the SARS-CoV-2 Spike Protein and Human ACE2 Receptor, Inhibiting Vero Cell Infection
by: Maria Ennemoser, et al.
Published: (2021-12-01)

Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain
by: Zachariah P. Schuurs, et al.
Published: (2021-01-01)

Potential Mechanisms of Cancer-Related Hypercoagulability
by: Nicola J. Nasser, et al.
Published: (2020-02-01)

Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation
by: Helena Crijns, et al.
Published: (2020-03-01)

The use of heparin and heparin-like molecules in cancer treatment: a review
by: Johnny Atallah, et al.
Published: (2020-01-01)

Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification
by: Yong Li, et al.
Published: (2016-01-01)

The amino acid sequences of the carboxyl termini of human and mouse hepatic lipase influence cell surface association
by: Robert J. Brown, et al.
Published: (2003-07-01)

Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
by: Aikaterini Berdiaki, et al.
Published: (2021-03-01)

Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate
by: Lauren A. Gandy, et al.
Published: (2022-11-01)

Heparan sulfates and heparan sulfate binding proteins in sepsis
by: Yi-En Liao, et al.
Published: (2023-02-01)

Glycomics Approaches for the Bioassay and Structural Analysis of Heparin/Heparan Sulphates
by: Jeremy E. Turnbull, et al.
Published: (2012-11-01)

Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
by: Anett Hudák, et al.
Published: (2022-01-01)

Editorial: Heparan sulfate-binding proteins in health and disease
by: Lauren A. Gandy, et al.
Published: (2024-03-01)

Heparanase: A Challenging Cancer Drug Target
by: Deirdre R. Coombe, et al.
Published: (2019-11-01)

Heparin Mimetics and Their Impact on Extracellular Matrix Protein Assemblies
by: Fabian Heide, et al.
Published: (2023-03-01)

Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress
by: Ghadah A. Karasneh, et al.
Published: (2021-09-01)

Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury
by: Kornelia Kuźnik-Trocha, et al.
Published: (2022-10-01)

TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid Arthritis
by: Anna Szeremeta, et al.
Published: (2022-07-01)

Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate
by: John Hogwood, et al.
Published: (2017-07-01)